Skip to main content


Fesik wins 2021 Chester Stock Award

Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer


Boehringer Ingelheim Expands Collaboration with Vanderbilt University for Difficult-to-Treat Cancers


VU  takes key role in cancer drug discovery consortium

Research News@Vanderbilt, June 23, 2016


Stephen Fesik Receives Grant W. Liddle Award for Outstanding Contributions in Clinical Research

Research News@Vanderbilt, May 5, 2016


Progress in the Search for Mcl-1-Targeted Anticancer Agents

VICB Featured Discoveries, March 7, 2016


Cancer: The Ras Renaissance

Nature, News Feature, 16 April 2015, Vol. 520, p. 278-280


Grant bolsters pancreatic cancer drug discovery efforts

Research News@Vanderbilt, January 29, 2015

Research Investigator Award Recipients,, 2015-2017


Boehringer Ingelheim and Vanderbilt University join forces to develop new Ras inhibitors for cancer treatment


Cancer’s Holy Grail: Innovative Method Takes Aim at “Undruggable” Proteins

Vanderbilt Magazine, Winter 2014, Vol. 95, No. 1, p. 34


Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange

PNAS, March 4, 2014, vol. 111 no. 9, 3401–3406

A new way to target cancer-driver Ras, Research News@Vanderbilt, March 13, 2014


Untangling RAS: An “undruggable” cancer-causing protein, 30 years of research and the national initiative that aims to finally make the connections 

Momentum, Fall 2013, November 21, 2013


Stephen W. Fesik presents the W. Dial Black Family Lecture at Baylor University

Baylor Media Communications, November 18, 2013


Discovery of an Inhibitor of Replication Protein A’s Protein-Protein Interactions

VICB Featured Discoveries, October 30, 2013


Steve Fesik Attended 2nd Annual Great Futures Gala Headed by Martin Sheen in Nashville, TN

Martin Sheen Headlines 2013 Great Futures Gala, Mid-TN Today, April 24, 2013


Taking Multiple Shots At Drug-Resistant Cancer: Technique directly links fragments to make a variety of small molecules that block hot target Mcl-1

Chemical & Engineering News (C&EN), January 8, 2013


Discovery of Mcl-1 Inhibitors Offer Hope for New Cancer Therapeutics

VICB Featured Discoveries, January 8, 2013

Grant renewal boosts GI cancer research program 

Reporter, September 20, 2012, p. 1


Targeting Cancer Through K-Ras

VICB Featured Discoveries, May 30, 2012


Reviving Ras

Science-Business eXchange, May 24, 2012


VanderbiltHealth video interview “My Health Chat: Cancer Drug Discovery” with Stephen W. Fesik, Ph.D. and Lawrence J. Marnett, Ph.D.

My Health Chat, April 2012


Stephen W. Fesik, Ph.D., Receives Sixth Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research

AACR Press Release, March 22, 2012

Carroll wins Vanderbilt’s first Damon Runyon Fellowship

Reporter, January 27, 2012, p. 3


Huge new magnet to enhance cancer drug discovery efforts 

Reporter, May 13, 2011, p. 6


Aileron Therapeutics Appoints Veterans of Life Sciences Industry and Wall Street to its BOD; Nobel Laureate and Venerated Drug Developers Join Company’s SAB

BusinessWire, May 11, 2011


A New Prescription for Drug Discovery

Vanderbilt Medicine, Winter 2011, Feature, p. 12-17


Fesik receives $2.5M grant from the Lustgarten Foundation to support his drug discovery research for the treatment of pancreatic cancer

Reporter, January 28, 2011, p. 3

  • VICC Press Release
  • People On the Move | Health Care, Nashville Business Journal, January 31, 2010


Fesik is elected the 2010 AAAS Fellow for distinguished contributions in the application of structural biology to medicinal chemistry and drug discovery

Reporter, January 14, 2011, p. 1-2


Fesik wins NIH Director’s Pioneer Award 

Reporter, August 13, 2010, p. 1-2


Fesik to hold new Ingram Chair in Cancer Research

Reporter, May 28, 2010, p. 1,4


Fesik Presents the 14th Annual Weinberg Memorial Lecture at Harvard Medical School

The Nucleus, 88(9), May, 2010, p. 9


Fesik Delivers the Keynote Address at the Joint Keystone Symposia: Computer-Aided Drug Design (Z7) and New Directions in Small Molecule Drug Discovery (Z8)

Keystone Symposia Web Announcement, April, 2010


VUMC’s Fesik lands technology innovation award

Reporter, January 8, 2010, p. 6


 More on the Menu: Expanding the Selection of Cancer Therapies 

 Momentum, Fall, 2009, p. 16-22


NIH grant bolsters search for new cancer drugs

Reporter, October 16, 2009, p. 3


 VU joins effort to develop new cancer therapies

Reporter, September 4, 2009, p. 1,4


Renowned cancer drug researcher joins Vanderbilt

Reporter, May 29, 2009, p. 2

(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),

ga(‘create’, ‘UA-77332372-1’, ‘auto’);
ga(‘send’, ‘pageview’);